We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.97T
| $231M | 1.81% |
9,664,860
+255,564
| +3% | +$6.35M |
|
|
2
Johnson & Johnson
JNJ
$640B
| $229M | 1.79% |
1,884,607
+133,473
| +8% | +$15.2M |
|
3
Microsoft
MSFT
$2.9T
| $184M | 1.44% |
3,590,397
+96,979
| +3% | +$5.04M |
|
|
4
ExxonMobil
XOM
$650B
| $154M | 1.2% |
1,644,187
+158,959
| +11% | +$14.1M |
|
|
5
AT&T
T
$164B
| $145M | 1.14% |
4,452,964
+479,320
| +12% | +$14.3M |
|
6
Procter & Gamble
PG
$340B
| $136M | 1.06% |
1,606,573
+119,953
| +8% | +$9.85M |
|
7
Alphabet (Google) Class A
GOOGL
$4.12T
| $120M | 0.94% |
3,425,340
+277,640
| +9% | +$10.2M |
|
8
Amazon
AMZN
$2.44T
| $119M | 0.93% |
3,337,240
+234,280
| +8% | +$7.92M |
|
9
GE Aerospace
GE
$364B
| $118M | 0.92% |
783,250
+9,294
| +1% | +$1.36M |
|
10
Pfizer
PFE
$143B
| $115M | 0.9% |
3,446,692
+355,484
| +11% | +$11.3M |
|
11
Berkshire Hathaway Class B
BRK.B
$1.1T
| $99.4M | 0.78% |
686,724
+56,002
| +9% | +$8.01M |
|
12
Coca-Cola
KO
$383B
| $96.7M | 0.76% |
2,132,757
+70,010
| +3% | +$3.16M |
|
13
PepsiCo
PEP
$196B
| $95.8M | 0.75% |
904,314
+64,786
| +8% | +$6.69M |
|
14
UnitedHealth
UNH
$382B
| $95.4M | 0.75% |
675,591
+32,509
| +5% | +$4.33M |
|
15
Meta Platforms (Facebook)
META
$1.49T
| $94.4M | 0.74% |
826,360
+70,607
| +9% | +$8.14M |
|
16
JPMorgan Chase
JPM
$916B
| $90.7M | 0.71% |
1,459,683
+59,832
| +4% | +$3.74M |
|
17
Merck
MRK
$322B
| $88.7M | 0.69% |
1,614,050
+216,747
| +16% | +$11.5M |
|
18
Walmart Inc
WMT
$909B
| $86.8M | 0.68% |
3,567,210
+471,879
| +15% | +$10.9M |
|
19
Cisco
CSCO
$443B
| $84.9M | 0.66% |
2,959,234
+460,247
| +18% | +$12.9M |
|
20
Home Depot
HD
$337B
| $84.5M | 0.66% |
661,751
+42,167
| +7% | +$5.58M |
|
21
Verizon
VZ
$197B
| $82M | 0.64% |
1,468,251
+160,923
| +12% | +$8.35M |
|
22
Wells Fargo
WFC
$254B
| $80.7M | 0.63% |
1,705,021
-86,419
| -5% | -$4.21M |
|
|
23
Novartis
NVS
$302B
| $80.3M | 0.63% |
1,085,458
+233,768
| +27% | +$16.2M |
|
|
24
IBM
IBM
$213B
| $79.6M | 0.62% |
548,573
+92,782
| +20% | +$13.3M |
|
25
Intel
INTC
$413B
| $79.4M | 0.62% |
2,421,744
+206,937
| +9% | +$6.48M |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.